Clarion has acquired the Digital Insurance Agenda

London based Clarion Events, one of the world’s leading independent event organisers, has announced it has acquired the Digital Insurance Agenda (DIA), the leading European event series serving the rapidly growing insurtech market.  The addition of DIA further enhances Clarion’s portfolio of events and digital platforms within the insurance market.  

read more

Arc partners with Bridge2Food

Arc, the global events, data, and media platform backed by investment funds managed by EagleTree Capital, announced today it has entered into an investment partnership with Bridge2Food, a membership and events business in the plant-based food and proteins industry

read more

Future acquires WhoWhatWear

Future plc (LSE: FUTR; “Future” or “the Group”), the global platform for specialist media, today announces the acquisition of WhoWhatWear, a leading digital-only women’s lifestyle publisher based in the US from Clique Brands Inc.

read more

A360 to acquire Bauer’s US business

Accelerate360, LLC’s A360 Media (“A360”) and Bauer Media Group today announced that A360 has entered into a definitive agreement to acquire Bauer’s U.S. publishing business. This transaction includes the print and digital assets of Woman’s World, First for Women and the Bauer U.S. bookazine business which produces more than 100 special interest publications per year. The transaction is expected to close in February 2022.

read more

Informa to divest Pharma Intelligence for £1.9bn

Informa (LSE: INF.L), the international B2B Markets, Knowledge Services and Business Intelligence Group today announced two significant steps in its 2021-2024 Growth Acceleration Plan II (“GAP II”). The Group has agreed to divest Pharma Intelligence, the largest business within its Informa Intelligence division

read more

Warburg Pincus acquires Pharma Intelligence from Informa

Warburg Pincus, a leading global growth investor, today announced the acquisition of Pharma Intelligence, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory compliance, from Informa PLC (LSE:INF.L), the international B2B markets knowledge services and business intelligence group. Mubadala Investment Company, the Abu Dhabi based investment company, joins Warburg Pincus in the investment. The investors plan to extend the company’s leading position in the pharmaceutical data and analytics market, investing in the creation of innovative products for its customers. Informa will retain 15% ownership in the company.

read more